PharmX Technologies Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for PharmX Technologies.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Software earnings growth | 28.0% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
What Is PharmX Technologies Limited's (ASX:PHX) Share Price Doing?
Feb 12A Look At The Intrinsic Value Of Corum Group Limited (ASX:COO)
Jul 12At AU$0.044, Is Corum Group Limited (ASX:COO) Worth Looking At Closely?
May 11Is Now The Time To Put Corum Group (ASX:COO) On Your Watchlist?
Nov 12At AU$0.089, Is It Time To Put Corum Group Limited (ASX:COO) On Your Watch List?
Apr 29Corum Group (ASX:COO) Is Posting Healthy Earnings, But It Is Not All Good News
Mar 02Corum Group Limited (ASX:COO) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Dec 13In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as PharmX Technologies has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2024 | 8 | 0 | 2 | 3 | N/A |
3/31/2024 | 7 | 0 | 5 | 7 | N/A |
12/31/2023 | 6 | 0 | 9 | 11 | N/A |
9/30/2023 | 6 | 0 | 8 | 11 | N/A |
6/30/2023 | 6 | -1 | 8 | 11 | N/A |
12/31/2022 | 2 | -1 | -1 | 3 | N/A |
9/30/2022 | 4 | -1 | -1 | 3 | N/A |
6/30/2022 | 5 | 0 | -1 | 3 | N/A |
3/31/2022 | 12 | 0 | -1 | 3 | N/A |
12/31/2021 | 12 | 0 | -1 | 3 | N/A |
9/30/2021 | 12 | 1 | -1 | 3 | N/A |
6/30/2021 | 12 | 1 | -1 | 3 | N/A |
3/31/2021 | 12 | 1 | -1 | 3 | N/A |
12/31/2020 | 11 | 1 | -1 | 2 | N/A |
9/30/2020 | 11 | 1 | -2 | 1 | N/A |
6/30/2020 | 11 | 0 | -3 | 0 | N/A |
3/31/2020 | 11 | -1 | -3 | 0 | N/A |
12/31/2019 | 10 | -2 | -3 | 0 | N/A |
9/30/2019 | 11 | -3 | -3 | 1 | N/A |
6/30/2019 | 11 | -4 | -2 | 1 | N/A |
3/31/2019 | 12 | -3 | -1 | 2 | N/A |
12/31/2018 | 12 | -2 | -1 | 3 | N/A |
9/30/2018 | 12 | -1 | -2 | 1 | N/A |
6/30/2018 | 13 | 0 | -3 | 0 | N/A |
3/31/2018 | 13 | -3 | N/A | 0 | N/A |
12/31/2017 | 14 | -6 | N/A | 0 | N/A |
9/30/2017 | 14 | -6 | N/A | 0 | N/A |
6/30/2017 | 15 | -6 | N/A | 0 | N/A |
3/31/2017 | 15 | -3 | N/A | -1 | N/A |
12/31/2016 | 16 | 1 | N/A | -1 | N/A |
9/30/2016 | 16 | 0 | N/A | -1 | N/A |
6/30/2016 | 17 | 0 | N/A | -1 | N/A |
3/31/2016 | 17 | 1 | N/A | N/A | N/A |
12/31/2015 | 17 | 1 | N/A | 2 | N/A |
9/30/2015 | 18 | 3 | N/A | 3 | N/A |
6/30/2015 | 18 | 5 | N/A | 4 | N/A |
3/31/2015 | 18 | 5 | N/A | N/A | N/A |
12/31/2014 | 18 | 5 | N/A | 5 | N/A |
9/30/2014 | 19 | 5 | N/A | 5 | N/A |
6/30/2014 | 19 | 4 | N/A | 6 | N/A |
3/31/2014 | 19 | 5 | N/A | 6 | N/A |
12/31/2013 | 19 | 5 | N/A | 6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if PHX's forecast earnings growth is above the savings rate (2.6%).
Earnings vs Market: Insufficient data to determine if PHX's earnings are forecast to grow faster than the Australian market
High Growth Earnings: Insufficient data to determine if PHX's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if PHX's revenue is forecast to grow faster than the Australian market.
High Growth Revenue: Insufficient data to determine if PHX's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PHX's Return on Equity is forecast to be high in 3 years time